# Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-a-novel-kappa-receptor-agonist-nalfurafine-hydrochloride-on-severe/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hitoshi Kumagai,Toshiya Ebata,Kenji Takamori,Taro Muramatsu,Hidetomo Nakamoto,Hiromichi Suzuki |
| Citations | 360 |
| DOI | 10.1093/ndt/gfp588 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/ndt/article-pdf/25/4/1251/5250871/gfp588.pdf |
| OpenAlex ID | https://openalex.org/W2140123841 |
| PMID | 19926718 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Hiromichi Suzuki](https://scholariq.org/researchers/hiromichi-suzuki/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.